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The causal role of breakfast in energy balance and health:
a randomized controlled trial in lean adults1–4
James A Betts, Judith D Richardson, Enhad A Chowdhury, Geoffrey D Holman, Kostas Tsintzas, and Dylan Thompson
ABSTRACT
Background: Popular beliefs that breakfast is the most important
meal of the day are grounded in cross-sectional observations that
link breakfast to health, the causal nature of which remains to be
explored under real-life conditions.
Objective: The aim was to conduct a randomized controlled trial
examining causal links between breakfast habits and all components
of energy balance in free-living humans.
Design: The Bath Breakfast Project is a randomized controlled trial
with repeated-measures at baseline and follow-up in a cohort in south-
west England aged 21–60 y with dual-energy X-ray absorptiometry–
derived fat mass indexes#11 kg/m2 in women (n = 21) and#7.5 kg/m2
in men (n = 12). Components of energy balance (resting metabolic
rate, physical activity thermogenesis, energy intake) and 24-h glyce-
mic responses were measured under free-living conditions with ran-
dom allocation to daily breakfast ($700 kcal before 1100) or
extended fasting (0 kcal until 1200) for 6 wk, with baseline and
follow-up measures of health markers (eg, hematology/biopsies).
Results: Contrary to popular belief, there was no metabolic adapta-
tion to breakfast (eg, resting metabolic rate stable within 11 kcal/d),
with limited subsequent suppression of appetite (energy intake remained
539 kcal/d greater than after fasting; 95% CI: 157, 920 kcal/d).
Rather, physical activity thermogenesis was markedly higher with
breakfast than with fasting (442 kcal/d; 95% CI: 34, 851 kcal/d).
Body mass and adiposity did not differ between treatments at
baseline or follow-up and neither did adipose tissue glucose uptake
or systemic indexes of cardiovascular health. Continuously mea-
sured glycemia was more variable during the afternoon and even-
ing with fasting than with breakfast by the final week of the
intervention (CV: 3.9%; 95% CI: 0.1%, 7.8%).
Conclusions: Daily breakfast is causally linked to higher physical
activity thermogenesis in lean adults, with greater overall dietary
energy intake but no change in resting metabolism. Cardiovascular
health indexes were unaffected by either of the treatments, but breakfast
maintained more stable afternoon and evening glycemia than did fasting.
This trial was registered at www.isrctn.org as ISRCTN31521726.
Am J Clin Nutr 2014;100:539–47.
INTRODUCTION
As recently identified in this and other journals, the belief that
breakfast benefits health remains merely a presumption, with an
outstanding need for causal data (1, 2). Epidemiology has consistently
associated infrequent breakfast consumption with increased risk of
adiposity, diabetes, and cardiovascular disease (3–7); yet, these
findings do not infer causality because habitual breakfast consumers
also tend to be nonsmokers, consume less fat and alcohol but more
fiber and micronutrients, and critically, are more physically active (6,
8–10). It therefore remains to be established whether daily breakfast
is a cause, an effect, or simply a marker of a healthy lifestyle.
Although much is known about the acute metabolic response over
the hours after a prescribed morning meal (11–18), longer-term
studies until now lacked measurement tools capable of accurately
monitoring all relevant metabolic and behavioral responses in free-
living humans. Moreover, previous experiments examined diets of
varied meal size, composition, and/or frequency (12–24), rather than
contrasting daily breakfast and extended morning fasting.
Physical activity thermogenesis is undoubtedly the most mal-
leable component of energy expenditure, yet the few studies that
specifically contrasted the relative presence or absence of regular
daily breakfast consumption were either not designed to measure
physical activity levels (25, 26) or were unable to detect changes in
heart rate or movement/step counts extrapolated from partial daily
records (8–11 h) by using wrist- or hip-worn monitors (23, 27).
Such indirect estimates of energy expenditure lack reliability when
applied to free-living conditions (28); neither do they provide the
necessary sensitivity to detect subtle or temporal alterations
in spontaneous low-to-moderate-intensity activities (29). We hy-
pothesized that activities of precisely this nature are most responsive
to modified eating patterns, and so provide novel insight by com-
bining in-depth laboratory tests [hematology, tissue biopsies, and
dual-energy X-ray absorptiometry (DXA)] with recent technologi-
cal advances in continuous monitoring of physical activity ther-
mogenesis and metabolic control in free-living humans (30).
SUBJECTS AND METHODS
Experimental design
The Bath Breakfast Project is a randomized controlled trial
comparing the effects of daily breakfast consumption relative to
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extended morning fasting on energy balance and human
health. This trial is registered with Current Controlled Trials
(ISRCTN31521726), and the procedures followed were in ac-
cordance with the protocol approved by the National Health
Service South-West 3 Research Ethics Committee (10/H0106/
13). This protocol has since been published in full (30), with trial
enrollment, baseline/eligibility testing, allocation, and follow-up
all conducted in accordance with Consolidated Standards of
Reporting Trials (CONSORT) guidelines (31). A CONSORT
flow diagram (Supplemental Figure 1 under “Supplemental data”
in the online issue), along with precise details of this protocol
and the rationale for our approach/methods (Supplemental
Figures 2 and 3 under “Supplemental data” in the online issue),
are provided as online supplementary materials with this article.
Here we report data for the lean cohort from the Bath Breakfast
Project, classified according to DXA-derived fat mass indexes
#11 kg/m2 for women and #7.5 kg/m2 for men (32), for whom
recruitment and follow-up spanned dates from 10 June 2010
until 16 May 2013. These individuals all met the following in-
clusion criteria: aged 21–60 y, record of regular menstrual cycle/
contraceptive use (if relevant), no anticipated changes in diet
and/or physical activity habits during the study period, weight
stable (within 1 kg over past 6 mo), non–shift workers, not
pregnant or breastfeeding, and free from any other condition or
behavior deemed either to pose undue personal risk or introduce
bias into the experiment.
Baseline demographic and anthropometric characteristics of
those who completed the trial are presented in Table 1. This
cohort completed intensive laboratory-based assessments at
baseline to determine their resting metabolic rate (via indirect
calorimetry from gaseous exchange) and anthropometric
characteristics, ie, DXA (Hologic Discovery W), waist and hip
circumference (ie, midpoint between lowest rib and iliac crest
and widest gluteal girth, respectively), and sagittal abdominal
diameter (by using an abdominal caliper at the iliac crest;
Holtain Limited). While participants remained in a 10-h
overnight fasted state (ie, 0900 6 1 h), a 15-mL blood sample
was drawn from an antecubital vein via an indwelling cannula
to determine the concentrations of key systemic metabolites/
hormones via commercially available spectrophotometric as-
says (HDL/LDL cholesterol, triacylglycerol, nonesterified fatty
acids, glucose, C-reactive protein; all from Randox Laborato-
ries) and ELISAs [IL-6; R&D Systems; insulin; Mercodia;
triiodothyronine (free-T3); ALPCO Diagnostics; thyroxine
(free-T4); ALPCO Diagnostics; leptin; R&D Systems; total
ghrelin and acylated ghrelin; Bertin Pharma; peptide YY and
glucagon-like peptide-1; Millipore; adiponectin; R&D Sys-
tems]. A small (w1 g) subcutaneous adipose tissue biopsy
sample was then taken from the abdomen to provide estimates
of tissue-specific insulin action [ie, insulin-stimulated (U-14C)-
D-glucose uptake]. Participants then undertook an oral-glucose-
tolerance test, which involved ingesting 75 g of glucose polymer
TABLE 1
Baseline demographic and anthropometric characteristics and changes at follow-up1
All participants (n = 33) Breakfast group (n = 16) Fasting group (n = 17)
Baseline
Change from
baseline (95% CI) Baseline
Change from
baseline (95% CI) Baseline
Change from
baseline (95% CI)
Age (y) 36 6 112 — 36 6 11 — 36 6 11 —
Women [n (%)] 21 (64) — 10 (63) — 11 (65) —
Frequent habitual breakfast
consumer3 [n (%)]
26 (79) — 11 (69) — 15 (88) —
Anthropometric measurements
Height (m) 1.73 6 0.08 — 1.75 6 0.09 — 1.71 6 0.07 —
BMI (kg/m2) 22.4 6 2.2 20.10 (20.21, 0.02) 22.0 6 2.2 20.04 (20.24, 0.16) 22.8 6 2.3 20.15 (20.27, 20.02)
DXA4
Fat mass index (kg/m2)
All 5.7 6 2.2 20.07 (20.21, 0.08) 5.4 6 2.2 20.06 (20.25, 0.12) 5.9 6 2.3 20.07 (20.31, 0.17)
Women 6.7 6 2.0 20.10 (20.30, 0.10) 6.5 6 2.1 20.05 (20.30, 0.21) 6.8 6 2.0 20.15 (20.49, 0.19)
Men 3.9 6 1.3 20.004 (20.24, 0.23) 3.6 6 1.0 20.09 (20.49, 0.31) 4.1 6 1.6 0.08 (20.32, 0.48)
Percentage body fat
All 25.1 6 8.5 20.2 (20.8, 0.3) 24.6 6 8.7 20.3 (21.1, 0.4) 25.6 6 8.5 20.1 (21.1, 0.8)
Women 29.7 6 6.6 20.3 (21.1, 0.4) 29.5 6 7.0 20.3 (21.2, 0.6) 29.8 6 6.6 20.4 (21.7, 0.9)
Men 17.2 6 4.7 20.02 (21.1, 1.0) 16.3 6 3.5 20.4 (22.1, 1.3) 18.0 6 5.8 0.4 (21.4, 2.1)
Waist circumference (cm) 76 6 6 20.7 (21.4, 20.1)* 75 6 6 20.9 (21.7, 20.05) 78 6 7 20.6 (21.7, 0.4)
Waist:hip ratio 0.78 6 0.07 20.01 (20.02, 0.001) 0.77 6 0.06 20.01 (20.02, 0.003) 0.80 6 0.07 20.01 (20.02, 0.002)
Sagittal abdominal diameter (cm) 18.4 6 1.5 20.5 (20.8, 20.2)* 18.3 6 1.7 20.5 (21.0, 20.01) 18.6 6 1.4 20.5 (20.9, 20.01)
Body mass (kg) 66.7 6 7.9 20.3 (20.6, 0.02) 67.0 6 8.3 20.2 (20.8, 0.4) 66.5 6 7.8 20.4 (20.8, 20.1)
DXA (kg)
Lean tissue mass5 47.1 6 8.7 20.08 (20.48, 0.33) 47.7 6 9.4 20.08 (20.72, 0.57) 46.4 6 8.1 20.08 (20.65, 0.49)
Adipose tissue mass 16.6 6 5.9 20.21 (20.63, 0.22) 16.2 6 5.7 20.21 (20.76, 0.34) 16.9 6 6.2 20.21 (20.91, 0.49)
1No variable differed significantly between groups at baseline, and there were no significant treatment3 time interactions. *P# 0.05. DXA, dual-energy
X-ray absorptiometry.
2Mean 6 SD (all such values).
3Defined as the ingestion of $50 kcal within 2 h of waking on most days of the week.
4DXA-derived fat mass index normal ranges = 5–9 kg/m2 (women) and 3–6 kg/m2 (men).
5Lean tissue mass excludes bone mineral content.
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in solution (Polycal; Nutricia) with 5-mL blood samples drawn
every 15 min for 2 h.
All the above measures were followed up 6 wk later, with free-
living assessments of energy intake (estimated from directly
weighed food diaries) and energy expenditure (combined heart
rate/accelerometry, Actiheart; CamNtech) monitored throughout
the first and last week of intervention, along with continuous
(5-min sampling interval) monitoring of interstitial glucose
concentrations via a subcutaneous abdominal catheter (iPro;
Medtronic) both to document chronic glycemic responses and to
verify compliance. Eumenorrheic women provided baseline
samples 2 wk before the start of the 6-wk intervention so that
follow-up samples could be acquired 3–10 d after the onset of
menses (ie, follicular phase). During the 6-wk intervention,
participants were randomly assigned (1:1 allocation ratio) to
either a group prescribed an energy intake of $700 kcal before
1100 daily, with at least half consumed within 2 h of waking
(breakfast group) or a group that extended their overnight fast by
abstaining from ingestion of energy-providing nutrients (ie,
plain water only) until 1200 each day (fasting group). The
randomization scheme was generated by the principal in-
vestigator (JAB) by using a computer-based random-number
generator and was stratified according to baseline breakfast
habits (block size = 4), with frequent breakfast consumption
defined as the ingestion of $50 kcal within 2 h of waking on
most days of the week. Investigators who enrolled participants
(JDR and EAC) were unaware of these details and indepen-
dently requested group assignments to prevent deciphering
of the allocation sequence. Because of the self-administered
nature of the treatments, it was impossible to blind participants
to group allocation and neither was it possible to blind in-
vestigators for many outcomes that either required direct in-
teraction with unblinded participants (eg, anthropometric
measurements and metabolic rate) or where treatment allocation
is immediately evident in the data (eg, diet records and con-
tinuous glucose monitoring). These same investigators then also
shared responsibility for completing various aspects of tissue
and data analysis. The intervention was applied under free-living
conditions, and all other lifestyle choices were allowed to vary
naturally. Compliance was confirmed via self-report and verified
via continuous glucose monitoring; one participant was ex-
cluded before follow-up for noncompliance, and 4 withdrew
before baseline measurements, but none attributed their with-
drawal to treatment allocation (Supplemental Figure 1 under
“Supplemental data” in the online issue); data reported herein
are therefore only for those individuals for whom baseline and
follow-up measurements were available (ie, a completers-only
analysis).
Data analysis
The primary outcome measures were a comprehensive as-
sessment of components of energy balance under free-living
conditions, which were averaged from the first and last week of
intervention and therefore expressed as simple summary statis-
tics, analyzed by using either paired or independent t tests for
contrasts within and between groups, respectively. Secondary
outcomes included regulatory/mechanistic data and markers of
cardiovascular health and metabolic control at baseline and
follow-up, for which treatment 3 time interactions were ex-
plored by using a mixed-model ANOVAwith baseline breakfast
habits included as a covariate. Most variables in this experiment
therefore involved a single comparison between 2-level scores
and so were not adjusted for multiple comparisons across the
different variables reported here. However, in cases in which
multiple comparisons were made within a given variable (ie,
physical activity thermogenesis was partitioned according to
intensity and time), a Holm-Bonferroni stepwise adjustment was
applied to prevent inflation of type I error rate (33). Statistical
analyses were performed by using IBM SPSS (version 21), with
significance accepted at an a level of P # 0.05. Values are
means with SDs in text and with SE bars in figures, with effects
expressed as change scores with 95% CIs.
RESULTS
Components of energy balance
Physical activity thermogenesis
The major component of energy balance that responded to
treatment was physical activity thermogenesis (breakfast com-
pared with fasting group: 1449 6 666 compared with 1007 6
370 kcal/d; P = 0.04). This overall treatment effect is apparent in
Figure 1 and partitioned in Figure 2 to show how and when
physical activity was accumulated, with a significant difference
between groups before 1200 daily (breakfast compared with
fasting group: 492 6 227 compared with 311 6 124 kcal/d; P =
0.01). Once classified according to accepted thresholds for the
intensity of physical activities (expressed as multiples of typical
resting metabolic rate, ie, a metabolic equivalent), the breakfast
group consistently engaged in more “light”-intensity physical
activity during the morning than did the fasting group (P =
0.03). There was no difference between treatment groups in
daily recordings of median (range) waking times [breakfast
compared with fasting group: 0727 (0625–0837) compared with
0708 (0630–0834) h] or sleeping times [breakfast compared
with fasting group: 2246 (2119–2329) compared with 2247
(2132–2334) h], such that mean sleep duration was very similar
between the breakfast group (483 6 39 min/night) and the
fasting group (476 6 44 min/night).
Resting metabolic rate
Baseline assessments of resting metabolic rate were closely
matched between the breakfast and fasting groups (ie, 1453 6
209 compared with 1452 6 179 kcal/d, respectively). The left
side of Figure 1 presents follow-up data for these respective
groups (ie, 1451 6 210 compared with 1462 6 146 kcal/d).
Resting metabolic rate was therefore stable within 11 kcal/d from
baseline to follow-up, with no difference between groups at
follow-up (11 kcal/d; 95% CI: 2120, 143 kcal/d).
Diet-induced thermogenesis
On the basis of established constants for the thermogenic effect
of each macronutrient reportedly ingested according to food
diaries (34), a small but consistent difference in diet-induced
thermogenesis was apparent between groups (Figure 1). Spe-
cifically, the greater energy intake reported by the breakfast group
led to an estimated proportionate difference in diet-induced
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thermogenesis (221 6 49 kcal/d) relative to the fasting group
(180 6 39 kcal/d; P = 0.01).
Energy intake
The breakfast group reported ingesting 2730 6 573 kcal/d rela-
tive to 21916 494 kcal/d reported by the fasting group (P = 0.007).
The right side of Figure 1 shows that the breakfast group
reported ingesting most of this additional energy in the
form of carbohydrate (337 6 94 compared with 249 6 58 g/d;
P = 0.004), particularly in the form of sugar (149 6 51 com-
pared with 966 38 g/d; P = 0.002). Analysis of the timing, type,
and quantity of foods consumed at given eating occasions
showed that overall daily eating patterns were unaffected by the
relative consumption or omission of a daily breakfast. Specifi-
cally, once unrestricted food intake was permitted (ie, 1200
onward each day), the breakfast and fasting groups exhibited
a similar frequency of consumption occasions defined as
“meals” (2.2 6 0.5 compared with 2.4 6 0.3 meals/d; P = 0.2)
and as “snacks” (2.1 6 0.7 compared with 2.1 6 0.8 snacks/d;
FIGURE 2. Physical activity thermogenesis under free-living conditions with either ingestion of $700 kcal before 1100 daily (breakfast group, n = 15) or
abstinence from all energy-providing nutrients until at least 1200 daily (fasting group, n = 15). Values are means 6 SEs partitioned by the time of day and
intensity of energy expenditure. The P value above the bar pertains to the overall comparison between groups; P values between the bars pertain to the specific
comparison for the relevant component. MET, metabolic equivalent.
FIGURE 1. Components of energy balance under free-living conditions with either ingestion of $700 kcal before 1100 daily (breakfast group) or
abstinence from all energy-providing nutrients until at least 1200 daily (fasting group). Values are means 6 SEs. Estimated energy intake values for
comparison of relative differences between groups are the average of the first [breakfast (n = 16) compared with fasting (n = 17): 2715 6 565 compared
with 21696 490 kcal/d; P = 0.01] and last [breakfast (n = 16) compared with fasting (n = 17): 27456 658 compared with 22146 584 kcal/d; P = 0.02] week
of intervention. Resting metabolic rate values (breakfast group, n = 16; fasting group, n = 16) were recorded at follow-up; diet-induced thermogenesis values
(breakfast group, n = 16; fasting group, n = 17) were estimated from reported energy intake; physical activity values are the average of the first [breakfast (n =
15) compared with fasting (n = 15): 14556 676 compared with 10156 433 kcal/d; P = 0.04] and last [breakfast (n = 15) compared with fasting (n = 15): 1443
6 705 compared with 998 6 423 kcal/d; P = 0.05] week of intervention. The P value above the bar pertains to the overall comparison between groups;
P values between the bars pertain to the specific comparison for the relevant component.
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P = 0.8), with no difference in the macronutrient composition of
these defined eating occasions (35) between groups.
Energy balance regulatory hormones
Thyroid hormones that regulate resting metabolic rate were
unresponsive to either of the treatments, with systemic con-
centrations of triiodothyronine (free-T3) and thyroxine (free-T4)
closely matched between treatments at baseline and follow-up
(Table 2). Similarly, a range of hormones implicated in the
regulation of appetite and energy balance also did not differ in
response between treatments. Fasted concentrations of leptin,
total ghrelin, acylated ghrelin, peptide YY, glucagon-like pep-
tide 1, and adiponectin are presented in Table 2, all of which
were equivalent at baseline between treatment groups and
showed no significant treatment 3 time interactions, such that
concentrations remained similar between treatments at follow-
up (although for adiponectin a significant effect of time was
apparent).
Health risk factors
Anthropometric measurements
Relative and absolute indexes of body mass and both whole-
body and central adiposity did not differ between treatments at
baseline or follow-up; therefore, there was no significant dif-
ference in the response over time between treatments (Table 1).
Cardiovascular health
The blood lipid profiles presented in Table 2 all approximate the
normal healthy range for each subfraction and for C-reactive protein
concentrations, with the exception of LDL cholesterol at follow-up
(ie, 131.3 6 27.0 mg/dL), which may be considered borderline
high for risk of cardiovascular disease events according to estab-
lished classifications (ie, .130 mg/dL) endorsed by the American
Heart Association (37). However, other than a small increase in
HDL cholesterol from baseline to follow-up in both groups, these
variables were unresponsive to either of the treatments.
TABLE 2
Baseline cardiovascular health, metabolic control and regulatory hormones, and changes at follow-up1
All participants (n = 33) Breakfast group (n = 16) Fasting group (n = 17)
Baseline
Change from
baseline (95% CI) Baseline
Change from
baseline (95% CI) Baseline
Change from
baseline (95% CI)
Cardiovascular health2
Total cholesterol (mg/dL) 193.1 6 34.73 7.7 (21.5, 15.1) 193.1 6 46.3 3.9 (27.7, 19.3) 193.1 6 23.2 7.7 (23.9, 19.3)
HDL cholesterol (mg/dL) 50.2 6 11.6 3.9 (2.3, 7.7)* 54.1 6 11.6 3.9 (1.2, 7.7) 50.2 6 11.6 3.9 (1.9, 7.7)
LDL cholesterol4 (mg/dL) 127.4 6 30.9 3.9 (23.9, 7.7) 123.6 6 34.7 0.4 (211.6, 11.6) 127.4 6 23.2 3.9 (23.9, 15.4)
Triacylglycerols (mg/dL) 75.2 6 25.7 23.5 (210.6, 3.5) 76.1 6 32.7 20.88 (212.4, 9.7) 74.3 6 16.8 25.3 (215.9, 5.3)
NEFAs (mg/dL) 16.33 6 7.04 20.28 (22.82, 2.54) 15.49 6 5.35 1.69 (22.25, 5.35) 17.18 6 8.45 21.97 (26.20, 1.97)
IL-6 (pg/mL) 2.18 6 1.30 20.07 (21.10, 0.97) 2.25 6 1.31 20.53 (21.21, 0.15) 2.11 6 1.33 0.37 (21.63, 2.37)
CRP (mg/L) 0.65 6 0.67 20.11 (20.31, 0.08) 0.79 6 0.82 20.13 (20.46, 0.21) 0.53 6 0.50 20.10 (20.36, 0.16)
Metabolic control
Glucose (mg/dL) 95.5 6 5.4 1.1 (21.1, 3.4) 95.5 6 5.4 1.1 (23.6, 5.4) 97.3 6 5.4 1.3 (21.8, 3.6)
Insulin (mIU/mL) 3.40 6 1.77 0.33 (20.23, 0.90) 3.37 6 2.15 0.35 (20.32, 1.00) 3.43 6 1.43 0.32 (20.67, 1.30)
HOMA-IR5 0.81 6 0.43 0.10 (20.05, 0.25) 0.79 6 0.52 0.10 (20.06, 0.26) 0.83 6 0.36 0.10 (20.16, 0.36)
C-ISI Matsuda index5 11.5 6 7.3 20.22 (21.66, 1.22) 12.1 6 6.6 20.97 (23.70, 1.77) 11.1 6 8.0 0.38 (21.29, 2.05)
Index of adipose insulin
sensitivity6 (%)
79.1 6 13.3 6.2 (0.2, 12.3)* 79.2 6 12.9 9.9 (0.8, 19.0) 79.1 6 14.1 3.3 (25.5, 12.1)
Regulatory hormones
Triiodothyronine (free-T3)
(pg/mL)
2.90 6 0.53 0.04 (20.10, 0.18) 2.84 6 0.63 0.04 (20.20, 0.28) 2.97 6 0.43 0.04 (20.15, 0.23)
Thyroxine (free-T4) (ng/dL) 1.23 6 0.16 0.04 (20.02, 0.10) 1.24 6 0.16 0.04 (20.05, 0.13) 1.21 6 0.16 0.04 (20.05, 0.13)
Leptin (mg/L) 8.3 6 7.5 0.4 (21.0, 1.8) 7.8 6 7.5 0.7 (21.5, 2.9) 8.8 6 7.6 0.2 (21.9, 2.2)
Total ghrelin (pg/mL) 405 6 163 27 (236, 22) 409 6 156 13 (233, 59) 400 6 174 229 (264, 7)
Acylated ghrelin (pg/mL) 137 6 70 5 (22, 13) 149 6 83 6 (25, 18) 126 6 55 4 (26, 15)
Peptide YY (pg/mL) 73.8 6 31.9 20.5 (27.8, 6.7) 66.5 6 28.6 22.8 (212.4, 6.8) 81.1 6 34.2 1.9 (210.4, 14.1)
GLP-1 (pg/mL) 16.50 6 14.19 3.96 (21.98, 9.90) 17.49 6 17.16 2.31 (22.97, 7.59) 15.18 6 10.56 5.61 (26.27, 17.49)
Adiponectin (mg/L) 8.9 6 3.4 0.8 (0.2, 1.5)* 9.8 6 3.4 0.4 (20.5, 1.3) 8.1 6 3.4 1.3 (0.3, 2.2)
1No variable differed significantly between groups at baseline, and there were no significant treatment3 time interactions. *P# 0.05. C-ISI, Composite-
Insulin Sensitivity Index; CRP, C-reactive protein; GLP-1, glucagon-like peptide 1; NEFA, nonesterified fatty acid; OGTT, oral-glucose-tolerance test; T3,
triiodothyronine; T4, thyroxine.
2 SI conversions: cholesterols 3 0.0259 = mmol/L; triacylglycerol 3 0.0113 = mmol/L; NEFA 3 0.0355 = mmol/L; IL-6 3 0.131 = IU/mL; CRP 3
9.524 = nmol/L; glucose 3 0.0555 = mmol/L; insulin 3 6.0 = pmol/L; free-T3 3 1.54 = pmol/L; free-T4 3 12.87 = pmol/L; leptin 3 0.0625 = nmol/L;
ghrelin 3 0.296 = pmol/L; peptide YY 3 4.31 = pmol/L; GLP-1 3 0.303 = pmol/L.
3Mean 6 SD (all such values).
4Calculated by using the Friedewald equation: LDL cholesterol = total cholesterol 2 HDL cholesterol 2 (triacylglycerol/2.2).
5HOMA-IR = [fasted insulin (mIU/mL) 3 fasted glucose (mmol/L)]/22.5; C-ISI Matsuda index = 10,000/O[fasted glucose (mg/dL) 3 fasted insulin
(mIU/mL)] 3 [mean glucose over 120-min OGTT (mg/dL) 3 mean insulin over 120-min OGTT (mIU/mL)].
6Based on insulin-stimulated adipose tissue [U-14C]-D-glucose uptake in cells treated with 50 pmol insulin/L expressed as a percentage of maximal/
supraphysiologic stimulation with 20 nmol insulin/L [as used previously (36)].
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Metabolic control
Fasted plasma glucose and serum insulin concentrations were
unaffected by 6 wk of either daily breakfast or extended morning
fasting (Table 2). Similarly, the HOMA-IR and Matsuda indexes
did not show any impact of either of the treatments on pancreatic
b cell function or whole-body insulin sensitivity. Similarly, the
index of insulin sensitivity specific to adipose tissue presented in
Table 2 showed no significant treatment 3 time interaction, nor
any significant difference between groups at follow-up. This
index is derived from the rates of tissue-specific glucose uptake
presented in Figure 3.
Subcutaneous glucose was monitored continuously throughout
the first and last week of intervention. Peak glucose concentra-
tions from waking until 1200 were consistently higher with
breakfast (7.6 6 1.2 mmol/L) than with fasting (6.5 6 1.0
mmol/L) throughout the first and last week (treatment effect:
F = 9.6, P , 0.01) with no treatment 3 time interaction.
Similarly, mean glucose concentrations during the morning did
not respond differently between treatments over time but were
significantly higher with breakfast (5.46 0.5 mmol/L) than with
fasting (5.1 6 0.5 mmol/L) when considered across both weeks
(treatment effect: F = 4.3, P = 0.05).
The CV (SD corrected for mean) is the preferred method for
expressing glucose variability (accumulated hyper-/hypoglycemic
episodes) when continuously monitored glucose data are avail-
able for individual patients (38). This measure is shown inFigure 4,
both from waking until 1200 (left side) and from 1200 until
sleep (right side). There was a nonsignificant trend across weeks
1 and 6 toward greater glucose variability before 1200 in the
breakfast group compared with the fasting group (treatment
effect: F = 3.9, P = 0.06). Conversely, the fasting group ex-
hibited greater glucose variability across weeks 1 and 6 from
1200 onward (treatment effect: F = 6.2, P = 0.02), with a non-
significant tendency to increase over the course of intervention
(treatment 3 time interaction: F = 3.6, P = 0.07) such that the
greatest group difference was apparent during week 6 (3.9%;
95% CI: 0.1%, 7.8%). Beyond the above effects, continuous
glucose monitoring showed similar peak, mean, and variability
values between groups during sleep, from 1200 until sleep, and
over the full 24-h period.
DISCUSSION
Here we provide the first report, to our knowledge, of all
components of energy balance with regular daily breakfast
relative to extended morning fasting measured under otherwise
free-living conditions. Contrary to popular belief, there was no
metabolic adaptation (ie, increased resting metabolism) to 6 wk of
daily breakfast nor any meaningful suppression of energy intake
later in the day. Rather, the major factor that compensated for the
prescribed difference in morning eating patterns was that regular
daily breakfast resulted in significantly higher physical activity
thermogenesis than occurred with extended morning fasting. This
difference in the energy expended via daily physical activities was
partially attributable to a significant difference in light-intensity
activities performed during the morning and has never previously
been objectively measured. Although fasting until 1200 every day
for 6 wk presented no negative cardiovascular effects as reflected
by the concentration of blood metabolites under fed and fasted
conditions, there was a 10% increase in adipose tissue insulin
sensitivity within the breakfast group. Conversely, those in the
fasting group exhibited no such effect on adipose tissue insulin
sensitivity (although this did not significantly differ from the
breakfast group at follow-up) but instead experienced pro-
gressively more variable interstitial glucose concentrations during
the afternoon/evening, with significantly less tightly regulated
glucose control than the breakfast group by the final week of the
intervention. Further research is required to establish whether
similar responses would be apparent in more overweight, less
healthy, and/or less physically active individuals.
FIGURE 3. Rates of [U-14C]-D-glucose uptake in adipocytes under basal, physiologic (50 pmol insulin/L), and supraphysiologic (20 nmol insulin/L)
conditions, measured at baseline and after 6-wk ingestion of $700 kcal before 1100 daily (breakfast group; n = 13) or abstinence from all energy-providing
nutrients until at least 1200 daily (fasting group; n = 16). Values are means 6 SEs. Three-factor ANOVA (treatment 3 time 3 insulin) showed a significant
effect of treatment (F = 4.2, P = 0.05) and insulin (F = 17.3, P , 0.001) with no significant effect of time nor any interaction of these factors. Ins, insulin.
544 BETTS ET AL
Because physical activity thermogenesis differed significantly
between treatments in light-intensity activities, this suggests that
breakfast may have affected spontaneous behaviors as opposed to
conscious decisions to participate in structured physical activity
or exercise. This reasoning may explain why attempts to explore
the causal effects of breakfast on energy expenditure by using
physical activity records/diaries would not be sensitive to such an
effect. Nonetheless, cross-sectional studies have detected slightly
higher self-reported overall physical activity levels among
breakfast eaters (39), and several recent cross-sectional studies
using accelerometry reported correlations between habitual
breakfast consumption and physical activity levels, particularly
during the morning (40, 41). The present study therefore shows
for the first time to our knowledge that these interesting corre-
lations do indeed have a causal component. In addition, the present
study shows the value of combined heart rate/accelerometry in
revealing not only total 24-h physical activity thermogenic re-
sponses but also temporal changes in physical activity patterns (ie,
when and how overall energy expenditure is accumulated).
The overall difference in physical activity thermogenesis
between the breakfast and fasting groups reported in this study
(Figure 2) was equally apparent whether considering the first
(1455 6 676 compared with 1015 6 433 kcal/d; P = 0.04) or
last (1443 6 705 compared with 998 6 423 kcal/d; P = 0.05)
week of intervention. This indicates that the effect of morning
eating patterns on physical activity levels may be direct and
immediate rather than secondary to accumulated physiologic
adaptations with sustained exposure to the presence or absence
of daily breakfast. One possible immediate mechanism is that an
increase in glucose availability may directly signal the transition
from the fasted to fed state and thus enable nonessential physical
activity energy expenditure above basal levels (40). Despite the
widespread belief that an extended period of fasting and/or
hypoglycemia can result in lethargy, this hypothesis has never
been empirically tested. Transient periods of reactive hypogly-
cemia (#3.3 mmol/L) between meals certainly do not explain
the general fatigue often attributed to “low blood sugar” (43),
yet no previous study has examined the effects of a more pro-
longed but less pronounced period of reduced glucose avail-
ability on physical activity levels in humans. The present study
therefore provides tentative evidence that skipping a morning
meal altogether and thus delaying the transition to fed-state
glucose availability may impose a limit on the amount of energy
expended via physical activities.
Overall reported dietary energy intake was 539 kcal/d lower
when fasting until 1200 than when consuming a breakfast of
$700 kcal before 1100 daily, with no difference between
treatments in terms of the frequency, timing, or composition of
meals consumed from 1200 onward. This reflects minimal di-
etary compensation for the energy deficit imposed by morning
fasting but also indicates that the treatment effect for afternoon/
evening glucose variability is not attributable to group differ-
ences in eating patterns during that period. Although it could be
contended that the higher afternoon/evening glucose variability
in the fasting group might simply reflect an initial transition
from a lower starting (ie, still fasted) value, this effect would be
apparent in the first week as well as in the last. The group dif-
ference in afternoon-evening glucose variability may instead
therefore be explained by the Staub-Traugott (or “second meal”)
effect, which describes how an initial meal can reduce the acute
glycemic response to subsequent feedings within hours of the
first (44). The present findings suggest that regularly skipping
breakfast may elicit adaptations to progressively increase sys-
temic glucose appearance and/or impair glucose disposal when
the overnight fast remains unbroken until after 1200.
On the basis of the distinct free-living responses of the
treatment groups reported here, it would clearly be informative to
have data characterizing participants’ habitual lifestyles in the
absence of intervention (particularly in terms of diet and phys-
ical activity habits). Given the already intensive nature of this
trial [including measures beyond those reported here (30)], ad-
ditional prolonged lifestyle monitoring was not deemed feasible
FIGURE 4. Glucose variability before and after 1200 (expressed as CVs) derived from subcutaneous glucose concentrations continuously monitored during
the first and last week of either ingesting $700 kcal before 1100 daily (breakfast group; n = 16) or abstaining from all energy-providing nutrients until
at least 1200 daily (fasting group; n = 16). Values are means 6 SEs. Two-factor ANOVA (treatment 3 time) showed a nonsignificant trend for treatment
(F = 3.9, P = 0.06) with no significant effect of time nor any interaction of these factors during the morning (left side of panel) and a significant effect of
treatment (F = 6.2, P = 0.02) with nonsignificant trends for time (F = 3.8, P = 0.06) and treatment 3 time (F = 3.6, P = 0.07) during the afternoon/evening
(right side of panel).
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because this could negatively affect recruitment/attrition rates
while also increasing the risk of measurement fatigue. However,
our main finding with regard to physical activity thermogenesis
is most likely a genuine response to treatment because of the
following 3 key interrelated reasons: 1) it is highly unlikely that
randomization of a group this size would generate such a marked
and consistent difference in this variable (442 kcal/d; 95% CI: 34,
851 kcal/d); 2) this difference was most consistently observed
during the morning, thus coincident with the time of day at which
treatments were applied; and 3) all of the other laboratory-based
variables that could be measured acutely before intervention were
equivalent between groups (ie, resting metabolic rate and all other
variables presented in Tables 1 and 2).
This study was designed to examine mechanisms linking daily
breakfast and components of energy balance in free-living
humans and not the long-term impact of breakfast habits on
weight change. Therefore, whereas we detected no significant
difference in weight loss between treatments (Table 1), longer-
term clinical trials are needed to examine the effects of continued
exposure to extended morning fasting. However, what can be
confidently concluded from the current data is that daily morning
fasting clearly did not cause weight gain in this population, as
might be hypothesized in view of epidemiologic evidence
showing positive associations between regularly skipping
breakfast and weight gain/status (3–6).
We conclude that daily breakfast is causally linked to higher
physical activity thermogenesis in lean adults, with limited evi-
dence of any dietary compensation later in the day nor any change
in resting metabolism. Blood metabolites indicative of cardio-
vascular health and metabolic control were not significantly af-
fected by breakfast or fasting and neither was there any difference
in adipose tissue glucose uptake between these treatments. However,
regular daily breakfast maintained more stable glucose responses
during the afternoon and evening.
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